Cynata Therapeutics Limited

ASX:CYP Stok Raporu

Piyasa değeri: AU$42.5m

Cynata Therapeutics Temettü

Temettü kriter kontrolleri 0/6

Cynata Therapeutics does not have a record of paying a dividend.

Anahtar bilgiler

n/a

Temettü verimi

-8.3%

Geri Alım Getirisi

Toplam Hissedar Getirisi-8.3%
Gelecekteki Temettü Verimin/a
Temettü Büyümesin/a
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettün/a
Ödeme oranın/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Here's Why We're Watching Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

Sep 21
Here's Why We're Watching Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

Will Cynata Therapeutics (ASX:CYP) Spend Its Cash Wisely?

May 29
Will Cynata Therapeutics (ASX:CYP) Spend Its Cash Wisely?

We're A Little Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Rate

Feb 09
We're A Little Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Rate

We're Interested To See How Cynata Therapeutics (ASX:CYP) Uses Its Cash Hoard To Grow

Feb 02
We're Interested To See How Cynata Therapeutics (ASX:CYP) Uses Its Cash Hoard To Grow

We Think Cynata Therapeutics (ASX:CYP) Can Easily Afford To Drive Business Growth

Sep 09
We Think Cynata Therapeutics (ASX:CYP) Can Easily Afford To Drive Business Growth

Here's Why We're Not At All Concerned With Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

May 26
Here's Why We're Not At All Concerned With Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

Here's Why We're Not Too Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

Dec 31
Here's Why We're Not Too Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

We're Not Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn

Aug 11
We're Not Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if CYP's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if CYP's dividend payments have been increasing.


Piyasaya Karşı Temettü Getirisi

Cynata Therapeutics Piyasaya Karşı Temettü Getirisi
CYP temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (CYP)n/a
Pazarın Alt %25'i (AU)2.6%
Pazarın En İyi %25'i (AU)6.1%
Sektör Ortalaması (Biotechs)2.2%
Analist tahmini (CYP) (3 yıla kadar)n/a

Önemli Temettü: Unable to evaluate CYP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate CYP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate CYP's payout ratio to determine if its dividend payments are covered by earnings.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as CYP has not reported any payouts.


Güçlü temettü ödeyen şirketleri keşfedin